Allogene Therapeutics Inc (NASDAQ:ALLO)

5.01
Delayed Data
As of Mar 22
 -0.32 / -5.97%
Today’s Change
5.00
Today|||52-Week Range
17.49
-20.35%
Year-to-Date

Today’s Trading

Previous close5.36
Today’s open5.33
Day’s range5.00 - 5.44
Volume2,482,610
Average volume (3 months)1,959,924
Market cap$790.4M
Data as of 4:00pm ET, 03/22/2023

Growth & Valuation

Earnings growth (last year)-22.80%
Earnings growth (this year)-4.61%
Earnings growth (next 5 years)+22.95%
Revenue growth (last year)-99.37%
P/E ratioNM
Price/Sales3,705.33
Price/Book1.20

Competitors

 Today’s
change
Today’s
% change
MCRBSeres Therapeutics I...-0.23-3.78%
IBRXImmunitybio Inc-0.22-11.68%
COGTCogent Biosciences I...-0.83-7.61%
ANIPANI Pharmaceuticals ...-1.09-2.74%
Data as of 4:00pm ET, 03/22/2023

Financials

Next reporting dateMay 10, 2023
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$243.0K
Annual profit (last year)-$332.6M
Net profit margin-136,885.60%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts